GetTopicDetailResponse(id=cbf411948ecf, topicName=免疫佐劑, introduction=, content=STING激動劑 免疫佐劑, image=null, comments=0, allHits=499, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Tue Sep 24 17:37:53 CST 2024, time=2024-09-24, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=496156, tagList=[TagDto(tagId=496156, tagName=免疫佐劑)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2227457, encodeId=9e80222e45707, content=<a href='/topic/show?id=5a7d106034ef' target=_blank style='color:#2F92EE;'>#STING激動劑#</a> <a href='/topic/show?id=cbf411948ecf' target=_blank style='color:#2F92EE;'>#免疫佐劑#</a>, objectTitle=浙江大學(xué)王杭祥團(tuán)隊《Cancer Research》：首次提出可離子化免疫佐劑用于抗腫瘤免疫治療, objectType=article, longId=844470, objectId=56198444e061, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240802/1722564517707_8538692.jpg, objectUrl=/article/show_article.do?id=56198444e061, replyNumber=0, likeNumber=75, createdTime=2024-09-24, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=56198444e061, moduleTitle=浙江大學(xué)王杭祥團(tuán)隊《Cancer Research》：首次提出可離子化免疫佐劑用于抗腫瘤免疫治療, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=56198444e061)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-09-24發(fā)表于上海
